Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Charles Gleason"'
Autor:
Jéromine Klingler, Shreyas Kowdle, Juan C. Bandres, Rozita Emami-Gorizi, Raymond A. Alvarez, Priyanka G. Rao, Fatima Amanat, Charles Gleason, Giulio Kleiner, Viviana Simon, Alexis Edelstein, Claudia Perandones, Chitra Upadhyay, Benhur Lee, Catarina E. Hioe
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAntibodies against the SARS-CoV-2 spike protein are a critical immune determinant for protection against the virus. While virus neutralization is a key function of spike-specific antibodies, antibodies also mediate Fc-dependent activities
Externí odkaz:
https://doaj.org/article/decc1bd9a5024a729a8bf1a0e2ce7ea7
Autor:
Ana S. Gonzalez-Reiche, Hala Alshammary, Sarah Schaefer, Gopi Patel, Jose Polanco, Juan Manuel Carreño, Angela A. Amoako, Aria Rooker, Christian Cognigni, Daniel Floda, Adriana van de Guchte, Zain Khalil, Keith Farrugia, Nima Assad, Jian Zhang, Bremy Alburquerque, PARIS/PSP study group, Levy A. Sominsky, Charles Gleason, Komal Srivastava, Robert Sebra, Juan David Ramirez, Radhika Banu, Paras Shrestha, Florian Krammer, Alberto Paniz-Mondolfi, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported in immune-compromised individuals and people undergoing immune-modulatory treatments. Although intrahost evolution has been documented, dir
Externí odkaz:
https://doaj.org/article/f68dd420466d4ce3b1c6402bfe4823dc
Autor:
Gagandeep Singh, Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, Juan Manuel Carreño, Viviana Simon, Florian Krammer
Publikováno v:
mBio, Vol 15, Iss 1 (2024)
ABSTRACTThe Orthocoronavirinae subfamily is large comprising four highly divergent genera. Four seasonal coronaviruses were circulating in humans prior to the coronavirus disease 2019 pandemic. Infection with these viruses induced antibody responses
Externí odkaz:
https://doaj.org/article/f7532f5095fe435c87cdd2cd06b4c5aa
Autor:
Disha Bhavsar, Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, Juan Manuel Carreno, Viviana Simon, Florian Krammer
Publikováno v:
mBio, Vol 14, Iss 6 (2023)
ABSTRACTCoronavirus disease 2019 (COVID-19) vaccines have saved millions of lives. However, variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged causing large numbers of breakthrough infections. These developments nec
Externí odkaz:
https://doaj.org/article/729951c538c54785904cf4b83ac9474a
Autor:
Kaori Sano, Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason, PARIS Study Group, Juan Manuel Carreño, Viviana Simon, Florian Krammer
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-8 (2022)
Prior exposure to infectious agents can impact the vaccination induced immune response. Here the authors show prior SARS-CoV-2 infection results in more efficient induction of mucosal SARS-CoV-2 secretory IgA antibody following mRNA vaccination.
Externí odkaz:
https://doaj.org/article/c69d1711a6744431874564ebc0b2cb78
Autor:
Jéromine Klingler, Gregory S. Lambert, Juan C. Bandres, Rozita Emami-Gorizi, Arthur Nádas, Kasopefoluwa Y. Oguntuyo, Fatima Amanat, Maria C. Bermúdez-González, Charles Gleason, Giulio Kleiner, Viviana Simon, Benhur Lee, Susan Zolla-Pazner, Chitra Upadhyay, Catarina E. Hioe
Publikováno v:
iScience, Vol 25, Iss 12, Pp 105608- (2022)
Summary: A fraction of patients with COVID-19 develops severe disease requiring hospitalization, while the majority, including high-risk individuals, experience mild symptoms. Severe disease has been associated with higher levels of antibodies and in
Externí odkaz:
https://doaj.org/article/b97299b033a14b1b9f3ad1f5125d6af4
Autor:
John Kubale, Charles Gleason, Juan Manuel Carreño, Komal Srivastava, Gagandeep Singh, Aubree Gordon, Florian Krammer, Viviana Simon
Publikováno v:
mBio, Vol 13, Iss 5 (2022)
ABSTRACT The PARIS (Protection Associated with Rapid Immunity to SARS-CoV-2) cohort follows health care workers with and without documented coronavirus disease 2019 (COVID-19) since April 2020. We report our findings regarding severe acute respirator
Externí odkaz:
https://doaj.org/article/575b0960d7ad43c99882ef0df8366a47
Autor:
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan Slamanig, D. Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S. Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
Publikováno v:
Science Translational Medicine. 15
NDV-HXP-S is a recombinant Newcastle disease virus–based vaccine against SARS-CoV-2, which expresses an optimized (HexaPro) spike protein on its surface. The vaccine can be produced in embryonated chicken eggs using the same process as that used fo
Autor:
Elham Kazemain, Jane Figueiredo, Jacek Skarbinski, Russell McBride, Viviana Simon, Amy B. Karger, F. Eun-Hyung Lee, Fred R. Hirsch, Andrea Cox, Sabra Klein, Rong Fan, Stephanie Halene, David A. Zidar, James M. Crawford, Bharat Thyagarajan, Charles Gleason, Alex Mathson, Komal Srivastava, Puleng Moshele, Toby Amoss, Martin Runnstrom, Susanne Linderman, Ananda M. Rodilla, Philip C. Mack, Yu Shyr, Anna Yin, Patrick Shea, Jennifer VanOudenhove, Hinnah Siddiqui, Brigid M. Wilson, Eric P. Elkin, Crystal A. Hsiao, Yonah Ziemba, Cheryl B. Schleicher, Sharon Fox, Lawrence H. Kushi, Karen Reckamp, Akil Merchant, Noah Merin
Publikováno v:
Cancer Research. 83:798-798
Introduction: COVID-19 vaccination substantially reduces morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe illness. However, despite effective COVID-19 vaccines many questions re
Autor:
Juan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, Komal Srivastava, Charles Gleason, Hiromi Muramatsu, Parnavi Desai, Judith A. Aberg, Rachel L. Miller, PARIS study group, Norbert Pardi, Viviana Simon, Florian Krammer
Publikováno v:
Vaccine. 40(42)
Two messenger RNA (mRNA)-based vaccines are widely used globally to prevent coronavirus disease 2019 (COVID-19). Both vaccine formulations contain PEGylated lipids in their composition, in the form of polyethylene glycol [PEG] 2000 dimyristoyl glycer